Logo image of GSK

GSK PLC-SPON ADR (GSK) Stock Analyst Earnings Estimates

NYSE:GSK - New York Stock Exchange, Inc. - US37733W2044 - ADR - Currency: USD

37.68  +0.12 (+0.32%)

After market: 37.7879 +0.11 (+0.29%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
GSK revenue by date.GSK revenue by date.
29.324B
18.74%
30.328B
3.42%
31.376B
3.46%
33.121B
5.56%
34.805B
5.08%
36.332B
4.39%
37.589B
3.46%
38.664B
2.86%
38.156B
-1.31%
37.644B
-1.34%
35.886B
-4.67%
EBITDA
YoY % growth
GSK ebitda by date.GSK ebitda by date.
10.542B
29.73%
10.598B
0.53%
10.688B
0.85%
11.254B
5.30%
12.142B
7.89%
12.765B
5.13%
13.306B
4.24%
13.391B
0.64%
13.451B
0.45%
12.301B
-8.55%
11.33B
-7.89%
EBIT
YoY % growth
GSK ebit by date.GSK ebit by date.
8.395B
46.03%
8.304B
-1.08%
8.137B
-2.01%
9.43B
15.89%
10.373B
10.00%
11.04B
6.43%
12.155B
10.10%
12.317B
1.33%
11.91B
-3.30%
10.051B
-15.61%
7.009B
-30.27%
Operating Margin
GSK operating margin by date.GSK operating margin by date.
28.63%27.38%25.93%28.47%29.80%30.39%32.34%31.86%31.21%26.70%19.53%
EPS
YoY % growth
GSK eps by date.GSK eps by date.
3.03
4.54%
3.18
4.85%
3.27
2.77%
3.55
8.58%
3.94
10.93%
4.20
6.64%
4.49
6.98%
4.56
1.63%
4.44
-2.72%
3.87
-12.79%
3.11
-19.74%

All data in GBP

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25
EPS
Q2Q % growth
0.98
-3.39%
0.53
11.19%
Revenue
Q2Q % growth
8.429B
5.20%
8.469B
4.34%
EBITDA
Q2Q % growth
2.883B
-35.72%
1.963B
-48.99%
EBIT
Q2Q % growth
2.694B
14.83%
1.593B
79.19%

All data in GBP

Recent Earnings VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
0.95
7.14%
0.890.077.67%
Q1 2025
Q2Q % growth
0.92
4.18%
0.840.089.85%
Q4 2024
Q2Q % growth
0.48
-19.72%
0.400.0718.46%
Q3 2024
Q2Q % growth
1.02
-1.39%
0.920.1010.89%
Q2 2024
Q2Q % growth
0.89
11.86%
0.800.0911.14%
Q1 2024
Q2Q % growth
0.88
16.49%
0.770.1114.88%
Q4 2023
Q2Q % growth
0.59
12.02%
0.60-0.01-1.98%
Q3 2023
Q2Q % growth
1.03
7.46%
0.980.055.56%
Q2 2023
Q2Q % growth
0.80
12.14%
0.740.067.52%
Q1 2023
Q2Q % growth
0.76
-8.92%
0.700.068.62%
Q4 2022
Q2Q % growth
0.53
-19.38%
0.470.0613.62%
Q3 2022
Q2Q % growth
0.96
2.51%
0.840.1214.45%
Q2 2022
Q2Q % growth
0.71
-1.49%
0.610.1016.49%
Q1 2022
Q2Q % growth
0.83
41.92%
0.800.044.62%
Q4 2021
Q2Q % growth
0.66
9.87%
0.650.011.36%
Q3 2021
Q2Q % growth
0.94
2.81%
0.770.1722.51%
Q2 2021
Q2Q % growth
0.72
46.35%
0.530.1935.82%
Q1 2021
Q2Q % growth
0.59
-38.77%
0.570.023.70%
Q4 2020
Q2Q % growth
0.60
-6.05%
0.61-0.02-2.81%
Q3 2020
Q2Q % growth
0.91
-7.77%
0.810.1113.09%
Q2 2020
Q2Q % growth
0.49
-37.05%
0.54-0.04-8.23%
Q1 2020
Q2Q % growth
0.96
24.25%
0.810.1518.15%
Q4 2019
Q2Q % growth
0.64 0.67-0.03-4.59%
Q3 2019
Q2Q % growth
0.99 0.880.1112.42%
Q2 2019
Q2Q % growth
0.78 0.660.1217.97%
Q1 2019
Q2Q % growth
0.77 0.670.1015.31%
GSK Yearly EPS VS EstimatesGSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4
Recent Revenue VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
7.986B
1.29%
7.989B-3M-0.04%
Q1 2025
Q2Q % growth
7.516B
2.08%
7.638B-122M-1.60%
Q4 2024
Q2Q % growth
8.117B
0.81%
7.983B134M1.68%
Q3 2024
Q2Q % growth
8.012B
-1.66%
8.298B-286M-3.45%
Q2 2024
Q2Q % growth
7.884B
9.84%
7.695B189M2.46%
Q1 2024
Q2Q % growth
7.363B
5.93%
7.279B84M1.15%
Q4 2023
Q2Q % growth
8.052B
9.16%
7.513B539M7.17%
Q3 2023
Q2Q % growth
8.147B
4.06%
7.964B183M2.30%
Q2 2023
Q2Q % growth
7.178B
3.59%
7.032B146M2.08%
Q1 2023
Q2Q % growth
6.951B
-3.32%
6.634B317M4.78%
Q4 2022
Q2Q % growth
7.376B
4.24%
7.563B-187M-2.47%
Q3 2022
Q2Q % growth
7.829B
18.14%
7.555B274M3.63%
Q2 2022
Q2Q % growth
6.929B
18.69%
6.702B227M3.39%
Q1 2022
Q2Q % growth
7.19B
-3.07%
9.265B-2.075B-22.40%
Q4 2021
Q2Q % growth
7.076B
-19.03%
9.782B-2.706B-27.66%
Q3 2021
Q2Q % growth
6.627B
-23.35%
8.986B-2.359B-26.25%
Q2 2021
Q2Q % growth
5.838B
-23.43%
7.785B-1.947B-25.01%
Q1 2021
Q2Q % growth
7.418B
-18.39%
8.12B-702M-8.65%
Q4 2020
Q2Q % growth
8.739B
-1.80%
9.001B-262M-2.91%
Q3 2020
Q2Q % growth
8.646B
-7.87%
9.034B-388M-4.29%
Q2 2020
Q2Q % growth
7.624B
-2.37%
7.953B-329M-4.14%
Q1 2020
Q2Q % growth
9.09B
18.65%
8.949B141M1.58%
Q4 2019
Q2Q % growth
8.899B 9.29B-391M-4.21%
Q3 2019
Q2Q % growth
9.385B 9.326B59M0.63%
Q2 2019
Q2Q % growth
7.809B 7.805B4M0.05%
Q1 2019
Q2Q % growth
7.661B 7.776B-115M-1.48%
GSK Yearly Revenue VS EstimatesGSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.21% -1.83% 0.26% 0.28%
Revenue-0.84% -1.5% -1.07% -1.52%